刺激性肠综合征的血清和便标志物:系统审查和元分析
Grace L Burns1, Freya Roberts2, Jasmine A Wark1
1College of Health, Medicine and Wellbeing, The University of Newcastle, Callaghan, Australia; Immune Health Research Program, Hunter Medical Research Institute, New Lambton Heights, Australia; NHMRC Centre of Research Excellence in Transforming Gut Health, New Lambton Heights, Australia.
这次系统性审查和元分析确定了刺激性肠综合征 (IBS) 的关键生物标志物. 血清细胞因子和便calprotectin的升高显示出对诊断IBS和区分其与有机疾病的希望.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 生物标志物发现发现
背景情况:
- 刺激性肠综合征 (IBS) 越来越多地被认为具有超出功能障碍分类的生物学基础.
- 尽管取得了进展,但IBS的客观诊断生物标志物仍然难以捉摸,严重依赖症状报告和排除.
- 这项研究旨在系统地审查和元分析IBS的血清和便生物标志物.
研究的目的:
- 在血清和便样本中识别出针对刺激性肠综合征 (IBS) 的一致和可靠的生物标志物.
- 为了区分IBS患者与健康对照和有机胃肠道疾病患者.
- 探索潜在的生物标志物,以区分IBS亚型.
主要方法:
- 在主要的医学数据库 (Medline,EMBASE,Cochrane,Web of Science,Scopus) 中进行了全面的系统搜索.
- 包括124项涉及14930名IBS患者,7544名健康对照和4317名有机疾病患者的研究.
- 分析使用标准化平均差异 (SMD) 与随机效应模型来评估血清和便标志物.
主要成果:
- 对IBS与健康对照的关键血清区分器包括TNF-α,IL-6和IFN-γ的升高.
- 与对照组相比,IBS患者的便calprotectin显著高于控制组,而酸则较低.
- 血清白蛋白和便calprotectin区分IBS和有机疾病;IL-6和白蛋白区分IBS与腹 (IBS-D).
结论:
- 在IBS患者中,外周细胞因子的升高表明上皮质的透性增加,并可能导致亚组的分化.
- 在IBS中便calprotectin的高,虽然低于有机疾病,但提供了一个诊断标记.
- 在IBS患者中发现的生物特征可能有助于临床诊断和阐明疾病机制.
更多相关视频
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
04:57Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
Published on: April 25, 2025
相关概念视频
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome III: Medical and Nursing Management
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Irritable Bowel Syndrome
